By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NKT Therapeutics Inc. 

233 Needham Street

Newton  Massachusetts  02464  U.S.A.
Phone: 617-454-1008 Fax: 617-454-1009


SEARCH JOBS


Industry
Biotechnology






Company News
NKT Therapeutics Inc. Reports First Clinical Results With Anti-iNKT Antibody In Patients With Sickle Cell Disease 12/10/2013 10:42:59 AM
NKT Therapeutics Inc. Presents Data on Potential Antibody Treatment for Sickle Cell Disease 12/6/2012 9:48:21 AM
DSM Pharmaceutical Products and NKT Therapeutics Inc. Sign Contract for Lead Product Development and Manufacture 2/8/2011 10:21:39 AM
DSM Biologics and NKT Therapeutics Inc. Sign Contract for Lead Product Development and Manufacture 2/8/2011 8:05:42 AM
NKT Therapeutics Inc. Announces Hiring of Barbara Finck, M.D. as Chief Medical Officer 10/5/2010 10:36:45 AM
BioWa and NKT Therapeutics Inc. Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Development 10/21/2009 9:34:57 AM
Selexis SA and NKT Therapeutics Inc. Enter Into Research Services Agreement 9/1/2009 11:05:09 AM
NKT Therapeutics Inc. Broadens Scientific Advisory Board with Three New Appointments 7/27/2009 8:36:40 AM
Antitope, Announces Antibody Research Agreement With NKT Therapeutics Inc. 4/9/2009 12:39:43 PM
NKT Therapeutics Inc. Closes Series A Venture Round Led by SV Life Sciences and MedImmune Ventures, Inc. 3/16/2009 7:23:43 AM
//-->